Teladoc Health, Inc. (NYSE:TDOC) Shares Sold by Mackenzie Financial Corp

Mackenzie Financial Corp lessened its stake in Teladoc Health, Inc. (NYSE:TDOC - Free Report) by 89.5% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 10,788 shares of the health services provider's stock after selling 92,165 shares during the quarter. Mackenzie Financial Corp's holdings in Teladoc Health were worth $98,000 as of its most recent filing with the SEC.

Several other hedge funds also recently added to or reduced their stakes in the stock. Vise Technologies Inc. boosted its holdings in shares of Teladoc Health by 4.9% in the fourth quarter. Vise Technologies Inc. now owns 30,179 shares of the health services provider's stock valued at $274,000 after acquiring an additional 1,405 shares in the last quarter. PharVision Advisers LLC purchased a new stake in Teladoc Health in the 4th quarter valued at about $301,000. Twinbeech Capital LP raised its position in shares of Teladoc Health by 63.8% in the 4th quarter. Twinbeech Capital LP now owns 382,735 shares of the health services provider's stock worth $3,479,000 after buying an additional 149,118 shares during the period. Two Sigma Advisers LP increased its position in Teladoc Health by 213.0% during the 4th quarter. Two Sigma Advisers LP now owns 2,258,711 shares of the health services provider's stock worth $20,532,000 after purchasing an additional 1,537,094 shares in the last quarter. Finally, Two Sigma Investments LP purchased a new position in Teladoc Health in the fourth quarter valued at about $18,348,000. 76.82% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity

In other news, insider Adam C. Vandervoort sold 11,011 shares of the business's stock in a transaction that occurred on Thursday, March 20th. The stock was sold at an average price of $8.42, for a total value of $92,712.62. Following the sale, the insider now directly owns 64,308 shares of the company's stock, valued at $541,473.36. The trade was a 14.62% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, insider Carlos Nueno sold 3,958 shares of the stock in a transaction dated Monday, June 2nd. The stock was sold at an average price of $6.86, for a total value of $27,151.88. Following the sale, the insider now owns 17,645 shares of the company's stock, valued at $121,044.70. This represents a 18.32% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 29,667 shares of company stock worth $220,901. 0.58% of the stock is currently owned by corporate insiders.

Teladoc Health Price Performance

Shares of NYSE:TDOC opened at $6.93 on Friday. Teladoc Health, Inc. has a twelve month low of $6.35 and a twelve month high of $15.21. The firm has a market capitalization of $1.21 billion, a price-to-earnings ratio of -1.20 and a beta of 1.82. The stock's 50 day moving average is $7.16 and its 200-day moving average is $9.14. The company has a quick ratio of 1.69, a current ratio of 1.73 and a debt-to-equity ratio of 0.66.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on the company. Needham & Company LLC restated a "hold" rating on shares of Teladoc Health in a research note on Thursday, May 1st. Truist Financial cut their price objective on Teladoc Health from $10.00 to $9.00 and set a "hold" rating for the company in a research report on Tuesday, May 27th. Jefferies Financial Group decreased their price objective on Teladoc Health from $10.00 to $8.00 and set a "hold" rating for the company in a research report on Monday, April 21st. Piper Sandler lowered their target price on Teladoc Health from $13.00 to $12.00 and set an "overweight" rating on the stock in a research note on Thursday, February 27th. Finally, Bank of America decreased their price target on shares of Teladoc Health from $8.00 to $7.00 and set a "neutral" rating for the company in a report on Wednesday, May 28th. Twelve research analysts have rated the stock with a hold rating and seven have given a buy rating to the company's stock. According to MarketBeat.com, Teladoc Health currently has a consensus rating of "Hold" and a consensus target price of $9.60.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.

Want to see what other hedge funds are holding TDOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teladoc Health, Inc. (NYSE:TDOC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.